Participation in clinical research studies is critical to the development of new standards of care. At TUCC, our research department is proud to provide patients with access to tomorrow’s urologic therapies today.
Clinical trials are designed by physicians and researchers to test new medical therapies. Depending on the study, these trials may give patients access to new investigational drugs and methods of care. The safety and privacy of clinical trial participants are protected through the Food and Drug Administration (FDA), the governing agency for all medical research. An independent Institutional Review Board (IRB) also reviews clinical trial related documents and procedures for patient safety and protection.
Patients who wish to enroll in a research study should discuss the possibilities with their urologist. The TUCC Clinical Research Department staff remains in constant communication with patients throughout their enrollment in clinical trials. These patients receive all study related medication and procedures at no cost. Participation is voluntary and patients can choose to withdraw from clinical trials at any time.
The TUCC Clinical Research Department participates in all phases of clinical trials for a variety of urologic conditions. Led by Clinical Research Director, Lawrence Karsh, M.D., C.P.I., the department is nationally recognized for its strong participation in urologic clinical trials.
In 2008, the TUCC Clinical Research Department was awarded acceptance into the Society of Urologic Oncology Clinical Trials Consortium. TUCC is one of only 22 large urology groups in the country with this designation. In addition, TUCC is an appointed, certified site for the South West Oncology Group (SWOG) to conduct bladder cancer clinical trials. The center is also an appointed, certified Radiation Therapy Oncology Group site to conduct prostate cancer clinical trials.
Lawrence I. Karsh, MD, FACS, CPI
Dr. Karsh is the primary investigator of research studies at TUCC. He has been involved in research since 1993 and has served as a principal investigator for hundreds of research studies. Dr. Karsh has also conducted workshops for clinical research and serves on advisory panels for investigational drugs.
Dr. Karsh is a Fellow of the American College of Surgeons and a member of the Denver Academy of Surgery and the American Urological Association. He is also an elected member of the Society of Urologic Oncology and is an editorial board member of OncologyLive Urologists in Cancer Care.
As director of the TUCC Clinical Research Department, Dr. Karsh has served as the principal investigator of more than 100 clinical trials. He is a current member of the bladder cancer sub-committee of the Society of Urologic Oncology Clinical Trial Consortium and an associate clinical professor of surgery at the University of Colorado Health Sciences Center. Dr. Karsh also sits on many advisory boards for new drug development and lectures at scientific meetings throughout the country.
Robin L. Dorsey, BA, CCRC
Manager, Clinical Research
Robin is a certified clinical research coordinator and has worked in the clinical research field for the past 18 years. She has conducted research in a wide variety of therapeutic areas including endocrinology, dermatology, rheumatology, respiratory, gastroenterology and neurology. She has been involved in urologic research for the past five years.
In addition, TUCC employs three full time dedicated clinical research coordinators and a full-time clinical research recruiter.
To learn more about what clinical trials are currently offered at TUCC, please click here. You can also call 303.421.5783 for more information.
Interested in finding out more about clinical trials at TUCC? Please fill out the following form and you will receive a response within one business day.